Håkansson, Kjell Erik Julius http://orcid.org/0000-0001-5804-0740
Guerrero, Silvia Cabrera
Backer, Vibeke http://orcid.org/0000-0002-7806-7219
Ulrik, Charlotte Suppli http://orcid.org/0000-0001-8689-3695
Rastogi, Deepa http://orcid.org/0000-0001-5714-9250
Funding for this research was provided by:
Trial Nation Denmark - Respiratory
Sanofi Genzyme, Denmark
Børnelungefonden, Denmark
Article History
Received: 15 December 2022
Accepted: 21 June 2023
First Online: 27 June 2023
Declarations
:
: Study approvals were granted by the Capital Region of Copenhagen’s Data Safety Board (ref. P-2021-602).
: As per Danish law, participant consent is not required for participation in and/or publication of aggregated data from nationwide cohorts sourced from Statistics Denmark.
: KEJH has received personal fees from AstraZeneca, Chiesi, GSK, Sanofi and TEVA. SCG declares no conflicts of interest. DR declares no conflicts of interest but does serve on a DSMB for the National Institute of Health. CSU has received personal fees from AstraZeneca, GSK, TEVA, Chiesi, Sanofi Genzyme, Boehringer-Ingelheim, Orion Pharma, Novartis, ALK-Abello, Mundipharma and Actelion. VB has received personal fees from AstraZeneca, GSK, TEVA, Sanofi Genzyme, MSD, Chiesi, Boehringer-Ingelheim, Novartis, ALK-Abello, Mundipharma, BIRK NPC and Pharmaxis.